{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
Back

A survey to assess the usage pattern of oxcarbazepine in the management of epilepsy in India

Survey Questionnaire Form
Doctor’s details
@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif

Questionnaire

  1. How many patients of epilepsy do you see in a month? *

  2. In your clinical practice, what percentage of your total patient population are diagnosed with epilepsy? *

  3. In your clinical practice epilepsy in more commonly found in? *

  4. In your clinical experience, epilepsy is more commonly diagnosed in which age group of patients? *

  5. Which diagnostic tests do you primarily use for epilepsy diagnosis? *

  6. How often do you prescribe oxcarbazepine for epilepsy management? *

  7. How do you approach AED selection in pediatric patients (4 -16 yrs. age group) with epilepsy? *

  8. What type of epilepsy do you primarily use oxcarbazepine to treat? *

  9. As per your clinical experience, which factors are critical for choosing first-line treatment option in the management of epilepsy? *

  10. What is the usual maintenance dose of oxcarbazepine in your practice for epilepsy? *

  11. How often do you titrate oxcarbazepine dosage in patients with epilepsy? *

  12. What percentage of your patients achieve seizure control with oxcarbazepine monotherapy? *

  13. What factors influence your decision to prescribe oxcarbazepine over other antiepileptics for epilepsy? *

  14. How do you assess the effectiveness of oxcarbazepine in your patients? *

  15. Do you use oxcarbazepine as monotherapy or in combination with other medications for epilepsy management? *

  16. What percentage of your epileptic patients currently take oxcarbazepine? *

  17. Do you consider oxcarbazepine as a first-line treatment option for elderly patients with epilepsy? *

  18. What is your preferred adjunctive therapy when adding oxcarbazepine to existing AED regimens? *

  19. How often do you educate patients with oxcarbazepine? *

  20. How often do you review and adjust oxcarbazepine dosages in stable patients? *

  21. How often do you inform patients about the importance of medication adherence with oxcarbazepine? *

  22. What is your approach for managing side effects associated with Antiepileptics? *

  23. How often do you switch patients from other antiepileptics to oxcarbazepine due to inadequate response or intolerable side effects? *

  24. What is your preferred monitoring interval for patients on Oxcarbazepine for epilepsy? *

  25. What is your preferred method for assessing treatment response to oxcarbazepine in epilepsy? *

  26. What are the most common reported patient concerns regarding use of antiepileptic therapy? *

  27. How do you educate patients about epilepsy and Oxcarbazepine? *

  28. How often do you encounter medication non-adherence among your patients with epilepsy? *

  29. What factors do you find most commonly contribute to medication non-adherence in epileptic patients? *

  30. What is your preferred approach to addressing medication non-adherence in epileptic patients? *

  31. What are your thoughts on the overall tolerability and efficacy of oxcarbazepine compared to other antiepileptics in the management of epilepsy? *